Geoffrey Warhurst

1.7k total citations
34 papers, 1.4k citations indexed

About

Geoffrey Warhurst is a scholar working on Clinical Biochemistry, Molecular Biology and Epidemiology. According to data from OpenAlex, Geoffrey Warhurst has authored 34 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Clinical Biochemistry, 9 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Geoffrey Warhurst's work include Bacterial Identification and Susceptibility Testing (10 papers), Drug Transport and Resistance Mechanisms (7 papers) and Infective Endocarditis Diagnosis and Management (6 papers). Geoffrey Warhurst is often cited by papers focused on Bacterial Identification and Susceptibility Testing (10 papers), Drug Transport and Resistance Mechanisms (7 papers) and Infective Endocarditis Diagnosis and Management (6 papers). Geoffrey Warhurst collaborates with scholars based in United Kingdom, Germany and France. Geoffrey Warhurst's co-authors include Gordon Carlson, Paul Dark, L A Turnberg, Malcolm Rowland, Jolanta Tanianis-Hughes, Yanling He, David W. Walker, John Ayrton, David R. Garrod and Christopher J.E. Watson and has published in prestigious journals such as Gastroenterology, PLoS ONE and Biochemical Journal.

In The Last Decade

Geoffrey Warhurst

34 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geoffrey Warhurst United Kingdom 22 413 297 274 226 184 34 1.4k
Elisabet I. Nielsen Sweden 28 367 0.9× 597 2.0× 143 0.5× 247 1.1× 173 0.9× 93 2.7k
Jacob Wulff United States 21 765 1.9× 268 0.9× 133 0.5× 206 0.9× 104 0.6× 34 1.6k
Shuping Li China 12 1.1k 2.8× 760 2.6× 245 0.9× 606 2.7× 174 0.9× 21 3.3k
Mohamed El Gazzar United States 35 1.4k 3.4× 620 2.1× 247 0.9× 147 0.7× 102 0.6× 82 3.8k
J. D. Baumgartner Switzerland 21 424 1.0× 905 3.0× 145 0.5× 98 0.4× 185 1.0× 35 2.6k
Marcin F. Osuchowski Austria 25 657 1.6× 1.0k 3.4× 102 0.4× 75 0.3× 208 1.1× 74 2.5k
Rosaria Santangelo Italy 24 944 2.3× 512 1.7× 333 1.2× 49 0.2× 156 0.8× 77 2.5k
Vesna Eraković Haber Croatia 25 606 1.5× 625 2.1× 171 0.6× 44 0.2× 131 0.7× 73 2.5k
Sha Wu China 14 582 1.4× 175 0.6× 71 0.3× 375 1.7× 56 0.3× 40 1.4k
Sylvie Saivin France 23 160 0.4× 366 1.2× 100 0.4× 57 0.3× 233 1.3× 75 1.7k

Countries citing papers authored by Geoffrey Warhurst

Since Specialization
Citations

This map shows the geographic impact of Geoffrey Warhurst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey Warhurst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey Warhurst more than expected).

Fields of papers citing papers by Geoffrey Warhurst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffrey Warhurst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey Warhurst. The network helps show where Geoffrey Warhurst may publish in the future.

Co-authorship network of co-authors of Geoffrey Warhurst

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffrey Warhurst. A scholar is included among the top collaborators of Geoffrey Warhurst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffrey Warhurst. Geoffrey Warhurst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Couto, Narciso, Zubida M. Al‐Majdoub, Brahim Achour, et al.. (2020). Quantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Intercorrelations in the Human Small Intestine. Drug Metabolism and Disposition. 48(4). 245–254. 77 indexed citations
2.
Harwood, Matthew D., Sibylle Neuhoff, Amin Rostami‐Hodjegan, & Geoffrey Warhurst. (2016). Breast Cancer Resistance Protein Abundance, but Not mRNA Expression, Correlates With Estrone-3-Sulfate Transport in Caco-2. Journal of Pharmaceutical Sciences. 105(4). 1370–1375. 5 indexed citations
4.
Warhurst, Geoffrey, Graham Dunn, Paul Chadwick, et al.. (2015). Clinical diagnostic accuracy study of rapid detection of sepsis-related health-care-associated bloodstream infection in intensive care using SeptiFast multipathogen real-time polymerase chain reaction technology. 1 indexed citations
5.
Warhurst, Geoffrey, Graham Dunn, Paul Chadwick, et al.. (2014). Diagnostic accuracy of SeptiFast multi-pathogen real-time PCR in the setting of suspected healthcare-associated bloodstream infection. Intensive Care Medicine. 41(1). 86–93. 37 indexed citations
6.
Harwood, Matthew D., Matthew R. Russell, Sibylle Neuhoff, Geoffrey Warhurst, & Amin Rostami‐Hodjegan. (2014). Lost in Centrifugation: Accounting for Transporter Protein Losses in Quantitative Targeted Absolute Proteomics. Drug Metabolism and Disposition. 42(10). 1766–1772. 37 indexed citations
7.
Dark, Paul, Bronagh Blackwood, Simon Gates, et al.. (2014). Accuracy of LightCycler® SeptiFast for the detection and identification of pathogens in the blood of patients with suspected sepsis: a systematic review and meta-analysis. Intensive Care Medicine. 41(1). 21–33. 83 indexed citations
8.
Dark, Paul, Claire Wilson, Bronagh Blackwood, et al.. (2012). Accuracy of LightCycler® Septi Fast for the detection and identification of pathogens in the blood of patients with suspected sepsis: a systematic review protocol. BMJ Open. 2(1). e000392–e000392. 28 indexed citations
10.
Dark, Paul, Graham Dunn, Paul Chadwick, et al.. (2011). The clinical diagnostic accuracy of rapid detection of healthcare-associated bloodstream infection in intensive care using multipathogen real-time PCR technology. BMJ Open. 1(1). e000181–e000181. 22 indexed citations
13.
Macutkiewicz, Christian, et al.. (2008). Characterisation of Escherichia coli strains involved in transcytosis across gut epithelial cells exposed to metabolic and inflammatory stress. Microbes and Infection. 10(4). 424–431. 31 indexed citations
14.
Collett, Andrew, Meritxell Gironella, Leo Zeef, et al.. (2008). Early molecular and functional changes in colonic epithelium that precede increased gut permeability during colitis development in mdr1a(−/−) mice. Inflammatory Bowel Diseases. 14(5). 620–631. 39 indexed citations
15.
16.
Tanianis-Hughes, Jolanta, et al.. (2005). Interferon γ Induces Translocation of Commensal Escherichia coli Across Gut Epithelial Cells via a Lipid Raft--Mediated Process. Gastroenterology. 128(5). 1258–1267. 148 indexed citations
17.
Lomax, Richard B., et al.. (1999). L-type calcium channels in enterochromaffin cells from guinea pig and human duodenal crypts: An in situ study. Gastroenterology. 117(6). 1363–1369. 37 indexed citations
18.
He, Yanling, Geoffrey Warhurst, Larry Gifford, et al.. (1998). Species Differences in Size Discrimination in the Paracellular Pathway Reflected by Oral Bioavailability of Poly(ethylene glycol) and d-Peptides. Journal of Pharmaceutical Sciences. 87(5). 626–633. 124 indexed citations
19.
Collett, Andrew, David W. Walker, Erika Sims, et al.. (1997). Influence of Morphometric Factors on Quantitation of Paracellular Permeability of Intestinal Epithelia In Vitro. Pharmaceutical Research. 14(6). 767–773. 30 indexed citations
20.
Collett, Andrew, Erika Sims, David W. Walker, et al.. (1996). Comparison of HT29-18-C1 and Caco-2 Cell Lines as Models for Studying Intestinal Paracellular Drug Absorption. Pharmaceutical Research. 13(2). 216–221. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026